IMPLANET (Euronext: IMPL, FR0010458729, PEA-PME eligible), a medical technology company specializing in vertebral and knee-surgery implants, today announces that it has received regulatory approval from the Brazilian National Health Surveillance Agency (ANVISA) to market its JAZZ BandTM platform. With almost